Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
Interview With Charles Gore, Medicines Patent Pool Executive Director

Charles Gore took over the role of Executive Director at the Medicines Patent Pool in July 2018, just after its board decided to greatly expand its mandate into essential medicines. Nine months into his term, IP-Watch’s William New talked with him about his role and how the expansion is going.

Published
24 March 2019
From
Intellectual Property Watch
Why 1 Top Analyst Thinks Gilead Sciences Will Soar More Than 25%

RBC Capital Markets analyst Brian Abrahams specifically mentioned a somewhat surprising reason to be excited about Gilead's prospects. He thinks that experimental HIV drug GS-6207 could be a transformative catalyst for Gilead. But GS-6207 is only in phase 1 clinical testing. It could take years for the drug to reach the market.

Published
24 March 2019
From
Motley Fool
A Farewell to Project Inform from HIV Research Advocate David Evans

The HIV community was dealt a sad blow this week when it was announced that the iconic non-profit HIV treatment advocacy organization, Project Inform, will end its programs. Project Inform’s Director of Research Advocacy, David Evans, has been working with the organization in various capacities for the last 27 years. In this message shared with My Fabulous Disease, David reflects on Project Inform’s legacy and on the influence of its legendary founder, Martin Delaney. We must all honor this legacy by ensuring that HIV treatment advocacy remain at the forefront of our movement.

Published
18 March 2019
From
My Fabulous Disease
LGBT+ health adviser urges Britain to make HIV-prevention drug free

Britain’s first national adviser for LGBT+ health has said the roll-out of a highly effective HIV prevention pill could save hundreds of thousands of pounds for the country’s publicly funded health authority. In an exclusive interview Michael Brady, who will take up the role on April 1, said a planned roll-out of pre-exposure prophylaxis (PrEP) - a once-daily pill that protects against HIV – in England would prove cost effective “very quickly”.

Published
18 March 2019
From
Reuters
New survey results indicate that Nigeria has an HIV prevalence of 1.4%

Expanded data collection and analysis provides better understanding of HIV epidemic in Nigeria

Published
14 March 2019
From
UNAIDS press release
9 New Members Named to President’s HIV Council—and They’re Meeting Right Now

PACHA had been empty over a year, after everyone quit or was fired by Trump.

Published
14 March 2019
From
Poz
Trump’s Proposed Budget Undermines His H.I.V. Plan, Experts Say

Strategies abound to end the AIDS epidemic, but expense — mostly for drugs costing up to $50,000 a year — is the inevitable obstacle.

Published
14 March 2019
From
The New York Times
Thailand’s achievements in HIV are not all widely implemented

“Thailand is progressing in the right direction to end AIDS, but needs sustained political and policy commitment with a sense of urgency for ‘the last miles’,” Dr

Published
12 March 2019
By
Roger Pebody
Wider ART Rollout Tied to Declines in HIV Mortality in Kenya

Both all-cause mortality and mortality among HIV-positive people dropped in Western Kenya following a scale-up of antiretroviral therapy (ART), a researcher said here. From 2011 to 2016, all-cause mortality dropped from 10.0 per 1,000 person years (95% CI 8.4-11.7) to 7.5 per 1,000 person years (95% CI 5.8-9.1), reported Emily C. Zielinski-Gutierrez, DrPH, of the CDC.

Published
12 March 2019
From
MedPage Today
Sadiq Khan: Cash row is denying Londoners access to HIV ‘wonder drug’

The London mayor said: “I’m shocked that the Government is failing to provide local authorities in London with the funding they need to provide PrEP to all those who could benefit.”

Published
12 March 2019
From
Evening Standard
← First12345...395Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.